Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
ASSETS    
Cash $ 296,381 $ 518,905
Prepaid expenses 44,991 73,865
Total current assets 341,372 592,770
Investments held in Trust Account 174,247,973 174,230,428
Total Assets 174,589,345 174,823,198
Current liabilities:    
Accounts payable 178,311 153,601
Accrued expenses 9,000 29,500
Accrued expenses - related party 83,333 53,333
Franchise tax payable 23,967 97,200
Promissory note - related party 267,000
Total current liabilities 561,611 333,634
Warrant liabilities 5,559,750 7,973,250
Total Liabilities 6,121,361 8,306,884
Commitments and Contingencies
Common stock subject to possible redemption, $0.0001 par value; 17,250,000 shares issued and outstanding at redemption value of $10.10 per share at March 31, 2022 and December 31, 2021 174,225,000 174,225,000
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 0 shares issued and outstanding at March 31, 2022 and December 31, 2021
Common stock, $0.0001 par value; 200,000,000 shares authorized; 4,312,500 shares issued and outstanding (excluding 17,250,000 shares subject to possible redemption) at March 31, 2022 and December 31, 2021 431 431
Additional paid-in capital
Accumulated deficit (5,757,447) (7,709,117)
Total Stockholders’ Deficit (5,757,016) (7,708,686)
TOTAL LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT $ 174,589,345 $ 174,823,198